Kumamoto, Japan

Sachio Okuda



Average Co-Inventor Count = 8.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Sachio Okuda: Innovating Botulinum Toxin Treatments

Introduction

Sachio Okuda, an accomplished inventor based in Kumamoto, Japan, has made significant contributions to the field of neurotoxin research, holding four patents to his name. His work focuses on developing innovative treatments for patients affected by botulinum toxins, specifically addressing challenges posed by neutralizing antibodies.

Latest Patents

One of Sachio Okuda's latest patents involves a novel approach to administering type A2 botulinum toxin preparation. This method treats patients who have developed neutralizing antibodies against type A1 botulinum toxin. By administering a 150 kDa type A neurotoxin derived from type A2 (A2 NTX), the clinical response in patients previously treated with type A1 can be effectively managed. Another significant patent features a neuromuscular transmission blocking agent composed of highly purified type A toxin from the infant botulism pathogen. This formulation presents a powerful medicament for conditions characterized by muscle overactivity, exhibiting rapid efficacy and a broader safety margin compared to conventional toxin preparations.

Career Highlights

Sachio Okuda has worked in notable research institutions, contributing his expertise to organizations such as the Chemo-Sero-Therapeutic Research Institute and the National Institute of Infectious Diseases in Japan. His innovative research has not only propelled advancements in treatment methodologies but also reinforced the scientific community's understanding of botulinum toxins.

Collaborations

Throughout his career, Okuda has collaborated with esteemed colleagues, including Yasushi Torii and Tetsuhiro Harakawa, with whom he has developed and refined his groundbreaking inventions. These partnerships have allowed him to further his research and enhance the therapeutic applications of neurotoxic agents.

Conclusion

Sachio Okuda’s contributions to the field of neurotoxins exemplify the spirit of innovation and dedication to improving patient outcomes. His latest patents reflect a commitment to addressing long-standing challenges in treatment, ensuring that patients receive effective and safe therapeutic options. With his ongoing work, Sachio Okuda continues to be a pivotal figure in medical research and invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…